Insider Trading
Zevra Therapeutics Insider Sold Shares Worth $474,774, According to a Recent SEC Filing
Rahsaan Thompson, Chief Legal & Compliance Officer, on August 14, 2026, sold 42,666 shares in Zevra Therapeutics (ZVRA) for $474,774. Following the Form 4 filing with the SEC, Thompson has control over a total of 37,569 common shares of the company, with 37,569 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1434647/000143464726000073/xslF345X05/wk-form4_1786998758.xml
$ZVRA
